BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17722972)

  • 21. Reaching out to clinicians: implementation of a computerized alert system.
    Degnan D; Merryfield D; Hultgren S
    J Healthc Qual; 2004; 26(6):26-30. PubMed ID: 15603092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse events targeted by drug-drug interaction alerts in hospitalized patients.
    Gatenby J; Blomqvist M; Burke R; Ritchie A; Gibson K; Patanwala AE
    Int J Med Inform; 2020 Nov; 143():104266. PubMed ID: 32961505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing adverse drug events in hospitalized patients.
    Evans RS; Pestotnik SL; Classen DC; Horn SD; Bass SB; Burke JP
    Ann Pharmacother; 1994 Apr; 28(4):523-7. PubMed ID: 8038479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detecting adverse drug events during the hospital stay].
    Berga Culleré C; Gorgas Torner MQ; Altimiras Ruiz J; Tuset Creus M; Besalduch Martín M; Capdevila Sunyer M; Torres Gubert M; Casajoana Cortinas MT; Baró Sabaté E; Fernández Solà JR; Moron i Besolí A; Odena Estradé E; Serrais Benavente J; Vitales Farrero MT; Codina Jané C
    Farm Hosp; 2009; 33(6):312-23. PubMed ID: 20038390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology, comparative methods of detection, and preventability of adverse drug events.
    Al-Tajir GK; Kelly WN
    Ann Pharmacother; 2005; 39(7-8):1169-74. PubMed ID: 15928265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of vendor computerized physician order entry on patients with renal impairment in community hospitals.
    Leung AA; Schiff G; Keohane C; Amato M; Simon SR; Cadet B; Coffey M; Kaufman N; Zimlichman E; Seger DL; Yoon C; Bates DW
    J Hosp Med; 2013 Oct; 8(10):545-52. PubMed ID: 24101539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the effectiveness of computerized adverse drug event monitoring systems to enhance clinical decision support for hospitalized patients.
    Petratos GN; Kim Y; Evans RS; Williams SD; Gardner RM
    Appl Clin Inform; 2010; 1(3):293-303. PubMed ID: 23616843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using a clinical data repository to estimate the frequency and costs of adverse drug events.
    Einbinder JS; Scully K
    Proc AMIA Symp; 2001; ():154-8. PubMed ID: 11833476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of adverse drug events and medication errors in a community hospital setting.
    Smith DS; Haig K
    Nurs Clin North Am; 2005 Mar; 40(1):25-32. PubMed ID: 15733944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a Computer-Assisted Adverse Drug Events Alarm and Assessment System for Hospital Inpatients in China.
    Chen C; Jia W; Guo D; Zhu M; Xu Y; Wang X; Wang D; Wang W; Tang Z
    Ther Innov Regul Sci; 2020 Jan; 54(1):32-41. PubMed ID: 32008241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
    Bates DW; Cullen DJ; Laird N; Petersen LA; Small SD; Servi D; Laffel G; Sweitzer BJ; Shea BF; Hallisey R
    JAMA; 1995 Jul; 274(1):29-34. PubMed ID: 7791255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Description of a computerized adverse drug event monitor using a hospital information system.
    Classen DC; Pestotnik SL; Evans RS; Burke JP
    Hosp Pharm; 1992 Sep; 27(9):774, 776-9, 783. PubMed ID: 10121426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RADARx: Recognizing, Assessing, and Documenting Adverse Rx events.
    Brown S; Black K; Mrochek S; Wood A; Bess T; Cobb J; Francis J
    Proc AMIA Symp; 2000; ():101-5. PubMed ID: 11079853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
    Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
    Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying Medication-Related Adverse Drug Events in Nursing Facilities in East Texas.
    Tenhunen ML; Smithers B; Tucker B
    Consult Pharm; 2016; 31(8):436-9. PubMed ID: 27535078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using pharmacogenetics knowledge to increase accuracy of alerts for adverse drug events.
    Mesika Y; Lee BC; Tsimerman Y; Roitman H; Park HK
    Stud Health Technol Inform; 2011; 169():569-73. PubMed ID: 21893813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of alert triggers for identification of developing adverse drug events.
    Moore C; Li J; Hung CC; Downs J; Nebeker JR
    J Patient Saf; 2009 Dec; 5(4):223-8. PubMed ID: 22130215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computerized surveillance for adverse drug events in a pediatric hospital.
    Kilbridge PM; Noirot LA; Reichley RM; Berchelmann KM; Schneider C; Heard KM; Nelson M; Bailey TC
    J Am Med Inform Assoc; 2009; 16(5):607-12. PubMed ID: 19567791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semi-Supervised Learning Algorithm for Identifying High-Priority Drug-Drug Interactions Through Adverse Event Reports.
    Liu N; Chen CB; Kumara S
    IEEE J Biomed Health Inform; 2020 Jan; 24(1):57-68. PubMed ID: 31395567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of laboratory monitoring alerts within a computerized physician order entry system for medication orders.
    Palen TE; Raebel M; Lyons E; Magid DM
    Am J Manag Care; 2006 Jul; 12(7):389-95. PubMed ID: 16834525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.